tirzepatide pediatric type 2 diabetes Big update in diabetes care ๐ฉบ Mounjaroยฎ (tirzepatide) is now SCALE KIDS Trial: Evaluating Liraglutide's
Description
Its given as a subcutaneous injection (under the skin) once weekly
Journal of Acquired Immune Deficiency Syndrome, 53 (3), 311-322
Usually, the dose wont be raised to more than 15 mg per week
Tirzepatide represents a valuable therapeutic option for our patients with type 2 diabetes and related metabolic disorders, supporting their journey toward better health and quality of life
However, the exploration of new drugs takes time
503A verification
